Cite
Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant.
MLA
Toh, H. C., et al. “Fluctuating Lymphocyte Chimerism, Tolerance and Anti-Tumor Response in a Patient with Refractory Lymphoma Receiving Non-Myeloablative Conditioning and a Haploidentical Related Allogeneic Bone Marrow Transplant.” Cytokines Cellular & Molecular Therapy, vol. 7, no. 2, June 2002, p. 43. EBSCOhost, https://doi.org/10.1080/13684730412331302054.
APA
Toh, H. C., Spitzer, T. R., Preffer, F., Alexander, S. I., McAfee, S., Dombkowski, D., Clark, J. S., Colby, C., Saidman, S., Sackstein, R., & Sykes, M. (2002). Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines Cellular & Molecular Therapy, 7(2), 43. https://doi.org/10.1080/13684730412331302054
Chicago
Toh, H.C., T.R. Spitzer, F. Preffer, S.I. Alexander, S. McAfee, D. Dombkowski, J.S. Clark, et al. 2002. “Fluctuating Lymphocyte Chimerism, Tolerance and Anti-Tumor Response in a Patient with Refractory Lymphoma Receiving Non-Myeloablative Conditioning and a Haploidentical Related Allogeneic Bone Marrow Transplant.” Cytokines Cellular & Molecular Therapy 7 (2): 43. doi:10.1080/13684730412331302054.